| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |